Last updated: 2026-10-06 12:25:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
QuidelOrtho Corporation (QDEL) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $12.10, with a market capitalization of $738.56M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.92 to $35.58. This page covers its latest market performance, valuation, price trends and company information.
$738.56M | |
$12.14 | |
$306.72 | |
$3.00 | |
$12.14 | |
639.00 | |
1.45M | |
-- | |
$35.58 | |
$9.92 | |
-- | |
-- |
QuidelOrtho Corporation (QDEL) is trading at $12.10 in pre-market trading as of 2026-10-06 12:22:00, down 0.33% ($0.04) from the previous close of $12.14
Pre-market trading shows how investors are pricing QDEL before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, QuidelOrtho Corporation (QDEL) moved from $10.94 to $12.10, representing a gain of 10.60% ($1.16).
The stock traded between $9.93 and $12.51 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.76 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 8.5%
QDEL is currently trading at $12.10, placing it 8.5% of the way from its 52-week low of $9.92 to its 52-week high of $35.58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 6500 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of QuidelOrtho Corporation (QDEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.